YouTube2Text

Everyone is About to Become Lean and Muscly (new evidence) — Transcript

by Dr Brad Stanfield · 2,089 words · 311 segments · language en · Watch on YouTube

Full transcript

  1. 0:00In 2024, a baby was born in Germany who
  2. 0:02by any measure was impossible. He was
  3. 0:04only a few days old and he already had
  4. 0:06visible muscles. His thighs and upper
  5. 0:08arms looked like a tiny bodybuilder.
  6. 0:11Doctors checked him for every disease
  7. 0:12that could explain it and they found
  8. 0:14nothing wrong. He wasn't sick. He was
  9. 0:16just extraordinarily, effortlessly
  10. 0:18strong. And when they looked at his
  11. 0:20genes, they found the answer. He'd been
  12. 0:22born with both copies of a single gene
  13. 0:24switched off. A gene that makes a
  14. 0:26protein called myostatin and myostatin,
  15. 0:29it turns out, has one job in your body
  16. 0:31to put the brakes on muscle growth. It's
  17. 0:33one of the reasons why you don't just
  18. 0:35keep adding on muscle forever. The
  19. 0:36baby's brakes were just gone and
  20. 0:38scientists that only found the myostatin
  21. 0:40gene about 7 years earlier in 1997. And
  22. 0:44the moment they understood what it did,
  23. 0:45the implications were staggering. If you
  24. 0:47could switch off the myostatin gene in
  25. 0:49anyone on purpose, you might be able to
  26. 0:52beat diseases that waste muscle away
  27. 0:54like muscular dystrophy or even
  28. 0:56sarcopenia. There was just one problem.
  29. 0:58For nearly 30 years, nobody could switch
  30. 1:00off the myostatin gene safely. But the
  31. 1:03breakthrough, which has only just been
  32. 1:04published, arrived in time to address a
  33. 1:06growing problem that didn't even exist
  34. 1:08in 1997. The problem is an unintended
  35. 1:11consequence of what's happened to weight
  36. 1:13loss over the past few years. So we have
  37. 1:15become incredibly, astonishingly good at
  38. 1:18melting fat away. So a decade ago, the
  39. 1:20best drugs took about 8% of your body
  40. 1:22weight off and with the burden of daily
  41. 1:24injections, most people just gave up.
  42. 1:26But then came semaglutide or Ozempic
  43. 1:29that increased weight loss to around %
  44. 1:32then to zepbound pushed it past 20% and
  45. 1:34the newest one in the line, a triple
  46. 1:36agonist drug called retatrutide, it took
  47. 1:38people down by 28% of their body weight
  48. 1:41loss in a big recent trial. So for
  49. 1:43someone starting at about 110 kg, that's
  50. 1:46more than 30 kg gone from a weekly
  51. 1:49injection. That's bariatric surgery
  52. 1:51territory, of course, without the
  53. 1:52surgery. But here's the catch and it's
  54. 1:54all over the internet right now. When
  55. 1:56you lose that much weight, some of what
  56. 1:58you lose is not fat. It's muscle, and
  57. 2:00you've probably seen what that can look
  58. 2:02like. If someone drops a huge amount of
  59. 2:04weight, they end up looking smaller, but
  60. 2:05they can also look a bit hollowed out
  61. 2:07and gaunt. So, some people started to
  62. 2:09panic that these drugs were melting
  63. 2:10people's muscle away. But, we do need
  64. 2:12some critical context here because the
  65. 2:14truth is far more boring and reassuring
  66. 2:16than the panic. So, when researchers
  67. 2:18pulled 22 trials of these drugs and
  68. 2:20added up exactly where that weight loss
  69. 2:22actually came from, about a quarter of
  70. 2:24it was muscle, and three quarters of it
  71. 2:26was fat. But, here's what most people
  72. 2:28miss. That 25% lean mass loss is not
  73. 2:31unique to Ozempic or other GLP-1
  74. 2:33medications. A quarter is roughly what
  75. 2:35you'd lose when you diet the
  76. 2:37old-fashioned way. It's roughly what you
  77. 2:39lose after weight loss surgery. Doctors
  78. 2:41have a decades-old rule of thumb that
  79. 2:42about a quarter of any weight that you
  80. 2:44lose is in lean tissue. Now, we can
  81. 2:47counteract some of this muscle mass loss
  82. 2:49by a good protein diet and regular
  83. 2:50resistance exercise. But, the dream
  84. 2:52result is that we only want to lose fat
  85. 2:55mass, not lean mass. We want to protect
  86. 2:57our muscles during this weight loss
  87. 2:58journey, and the key to that holy grail
  88. 3:00of losing fat and not muscle brings us
  89. 3:03to myostatin. In 1997, researchers bred
  90. 3:06mice with the myostatin gene deleted,
  91. 3:08and the mice, they grew enormous. They
  92. 3:09look exactly like the double-muscled
  93. 3:12cattle that farmers had bred for
  94. 3:13centuries. They were bulging, blocky,
  95. 3:15with twice the muscles of a normal mouse
  96. 3:17from a single gene switched off. So, the
  97. 3:20dream here is obvious. If turning off
  98. 3:22the myostatin gene doubles muscle mass
  99. 3:24in a mouse, then a drug that turns it
  100. 3:26off in a person could rebuild the wasted
  101. 3:29muscles of dystrophy or of old age. And
  102. 3:32then in 2004, proof that it might be
  103. 3:34safe in humans came from that German
  104. 3:36baby. It was an example of a natural
  105. 3:38human myostatin knockout walking around
  106. 3:41who was extraordinarily strong and
  107. 3:43completely healthy. If we managed to
  108. 3:44turn this gene off, it seemed, then
  109. 3:46nothing appeared to break. So, the
  110. 3:48target was obvious, and the safety
  111. 3:49looked reassuring, and the prize was
  112. 3:52enormous. And then for nearly 30 years,
  113. 3:54almost everyone who tried to hit this
  114. 3:56target failed. But why? Well, the tool
  115. 3:58that you'd use is a monoclonal antibody.
  116. 4:01Think of it like a guided missile that
  117. 4:03scientists designed to lock in onto one
  118. 4:04specific molecule shape and then
  119. 4:06neutralize it. The problem is that when
  120. 4:08myostatin is switched on, it looks
  121. 4:10almost identical to a whole family of
  122. 4:12related proteins that your body needs
  123. 4:14for other jobs. So, the missile aimed at
  124. 4:16active myostatin, it tends to hit its
  125. 4:19other cousins, too. And that's when you
  126. 4:20get side effects, or you blunt things
  127. 4:22that you never meant to touch. So, after
  128. 4:24decades of attempts, the verdict in the
  129. 4:26field became almost a punchline. Great
  130. 4:28expectations, but with limited success.
  131. 4:30So, the breakthrough was about being
  132. 4:31more precise. So, the newest drug,
  133. 4:34called apitegromab, it doesn't go after
  134. 4:36active myostatin, where all the
  135. 4:38look-alike cousins are. Instead, it
  136. 4:40grabs the myostatin earlier in its
  137. 4:42inactive, folded-up precursor form,
  138. 4:44before it's ever switched on. And that
  139. 4:46precursor shape is far more unique.
  140. 4:48Nothing else in the family looks quite
  141. 4:50like it. So, the missile finally locks
  142. 4:52on to myostatin and only myostatin, and
  143. 4:55it leaves everything else alone. That
  144. 4:57selectivity, as in hitting one target
  145. 4:59cleanly, is the exact thing that 30
  146. 5:01years of attempts have been missing. And
  147. 5:03before anyone ever pointed the strike at
  148. 5:05weight loss, it earned its stripes
  149. 5:07somewhere far more demanding.
  150. 5:09Apitegromab, it was first tested in
  151. 5:11spinal muscular atrophy, a brutal
  152. 5:13genetic disease that destroys muscles of
  153. 5:15children. In trials there, it improved
  154. 5:18motor function in kids who were losing
  155. 5:19it. And it did so safely. So, the tool
  156. 5:22had finally matured. We finally had a
  157. 5:24clean, selective, human-proven way to
  158. 5:26take the break off muscle formation. And
  159. 5:29it matured at the exact moment that the
  160. 5:30world handed it a brand new use. Because
  161. 5:33just as apitegromab was proving itself,
  162. 5:35the new weight loss drugs, they were
  163. 5:36driving fat loss faster than medicine
  164. 5:39had ever seen. So, does this approach
  165. 5:41work by combining GLP-1 medications, or
  166. 5:43the weight loss medications, with
  167. 5:45myostatin inhibitors? Well, yes, but
  168. 5:47there are problems. So, there were two
  169. 5:49medications that were leading the race
  170. 5:51to apply this breakthrough in muscle
  171. 5:53preservation to the problem of muscle
  172. 5:55loss during weight loss. So, they
  173. 5:56represent two completely different
  174. 5:58philosophies on how aggressive you
  175. 5:59should be. So, the first one we've
  176. 6:01already talked about, a pigaveramab,
  177. 6:03it's the clean one. It does exactly what
  178. 6:05we just described. It selectively blocks
  179. 6:07myostatin, but it's bimagrumab that's
  180. 6:10the showstopper. And instead of just
  181. 6:11blocking myostatin, it blocks a broader
  182. 6:14docking port, the active receptor, which
  183. 6:16is a much heavier hand on the whole
  184. 6:18system. And on its own, it does
  185. 6:19something that no diet drug does. So,
  186. 6:21people's muscles actually grew as their
  187. 6:24fat fell, though the total weight loss
  188. 6:26was modest. So, if you bolt it onto
  189. 6:27semaglutide, you get the headline
  190. 6:29number, substantial weight loss, about
  191. 6:3192% of it from fat, with muscle largely
  192. 6:34protected. So, the muscle mass loss is
  193. 6:36much smaller here compared to
  194. 6:38semaglutide alone. And it's genuinely
  195. 6:40the closest thing that anyone has made
  196. 6:42to the lean and ripped from a vial. But
  197. 6:44that power comes with serious downsides.
  198. 6:46Most people on bimagrumab, they got
  199. 6:48muscle spasms. About a third of them got
  200. 6:50acne, and more seriously, it pushed up
  201. 6:53their LDL cholesterol, the kind that can
  202. 6:55build up in blood vessels, by as much as
  203. 6:5717%. So, that is the wrong direction for
  204. 7:00your heart. And then quietly, in
  205. 7:01September 2025, the company developing
  206. 7:04one of the big bimagrumab combinations
  207. 7:07paused their program because of these
  208. 7:08safety signals. All of this creates a
  209. 7:10lingering worry that if we start using
  210. 7:12these drugs to protect our muscles,
  211. 7:14maybe they start creating problems with
  212. 7:16our hearts. But if you can push gently,
  213. 7:18maybe that's when you can spare the
  214. 7:20muscles cleanly and not have any of
  215. 7:22these side effects, which is exactly why
  216. 7:24the gentle clean drugs, or the a
  217. 7:25pigaveramab, matters so much. The whole
  218. 7:28bit is that you can protect your muscles
  219. 7:30without poking the heart. So, does it
  220. 7:32work? Well, this is the trial that
  221. 7:33inspired this video. It's called
  222. 7:35Embrace, and the design is beautifully
  223. 7:38simple. So, they took 102 adults with
  224. 7:40obesity, and every single one of them
  225. 7:42were put onto Zepbound, and then they
  226. 7:44split them into two groups. So, one half
  227. 7:46also got the apitegromab, the muscle
  228. 7:48protector, and the other half got a
  229. 7:50dummy infusion on top. Neither patients
  230. 7:52nor the doctors knew who got which.
  231. 7:54After 6 months, they measured everyone
  232. 7:56and measured precisely how much of the
  233. 7:58weight that was lost was from fat and
  234. 8:00how much was from lean mass. And the
  235. 8:02combination appeared to work. So, the
  236. 8:04group on the apitegromab, they lost
  237. 8:06about half as much lean mass compared to
  238. 8:09the placebo group. Both groups lost
  239. 8:11about the same amount of weight, but in
  240. 8:12the apitegromab group, a far bigger
  241. 8:14share of that weight was fat, about 85%
  242. 8:17fat versus 70% in the placebo group. So,
  243. 8:20this gives us the first hint that we
  244. 8:22might hit the holy grail in the future
  245. 8:24where we can lose fat mass and also
  246. 8:26protect our lean mass, where we can get
  247. 8:28the best of both worlds and do it
  248. 8:30safely. But, we also need to be clear
  249. 8:31about what the study found because
  250. 8:33there's a key result that the headlines
  251. 8:35skipped. So, the apitegromab group, they
  252. 8:37were not measurably stronger. The trial
  253. 8:39tested it directly. So, they used grip
  254. 8:41strength and how easily people could
  255. 8:43stand up and then sit back down in a
  256. 8:44chair. So, on both measures, the muscle
  257. 8:47protected group were no better than the
  258. 8:49dummy injection group. The drug kept the
  259. 8:51muscle on the scan, but that extra
  260. 8:52muscle, it didn't let people do anything
  261. 8:54more with their bodies. And those are
  262. 8:56two different things. Keeping lean mass
  263. 8:58that shows up on a scan is the means,
  264. 9:00but being stronger and more capable and
  265. 9:02less frail, that's actually the goal.
  266. 9:04And only the first one was proven here.
  267. 9:06Instead, this trial represents again
  268. 9:07where the future is potentially headed
  269. 9:09where we can all be a healthy weight and
  270. 9:11still have strong muscles no matter our
  271. 9:13age, but more work is needed. And a few
  272. 9:16blunt words on what the internet will
  273. 9:17try and sell you here. So, if you search
  274. 9:19how to keep muscle on Ozempic, you'll
  275. 9:21likely fall into a world of gray market
  276. 9:23scams and muscle peptides with names
  277. 9:26like YK11 for protecting muscle during
  278. 9:28weight loss. These essentially have no
  279. 9:30proper human evidence in the form of
  280. 9:32well-designed and conducted randomized
  281. 9:34controlled trials. What they have
  282. 9:35instead is a real track record of liver
  283. 9:37damage and even worse. So, in my
  284. 9:39opinion, they're not worth your money
  285. 9:41and not worth your liver's health.
  286. 9:42Instead, here's what to actually do
  287. 9:44about muscle loss while you're on GLP-1
  288. 9:46medications today. So, the thing that
  289. 9:48works right now with no prescription and
  290. 9:50no risk is the unglamorous one,
  291. 9:52resistance training a couple of times a
  292. 9:54week and enough protein in your diet.
  293. 9:56That is the part that you can control
  294. 9:58and it already works. For me personally,
  295. 10:00I take 1.25 mg of tirzepatide a week
  296. 10:03myself and I protect my muscles by doing
  297. 10:05exactly this, by doing resistance
  298. 10:07exercise and eating enough protein. And
  299. 10:09one supplement worth considering is
  300. 10:11creatine. It's the most studied
  301. 10:12ingredient there is for muscle and
  302. 10:14strength. And one last thing, I just
  303. 10:16mentioned that I take tirzepatide, not
  304. 10:18the newer and more powerful retatrutide.
  305. 10:20And there's a very good reason for this.
  306. 10:22And there's also a good reason why I
  307. 10:23take one of these medications even
  308. 10:25though I'm lean and non-diabetic. So,
  309. 10:27make sure to check out this next video
  310. 10:29here where I lay out all of my
  311. 10:30reasoning.

About this transcript

This page contains the full transcript of Everyone is About to Become Lean and Muscly (new evidence) by Dr Brad Stanfield, generated from the public captions YouTube serves with the video. The transcript has 2,089 words across 311 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to translate the transcript into 100+ languages.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, translation to 100+ languages, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.